'The time is now' for Australia to harness new vaccine techn

‘The time is now’ for Australia to harness new vaccine technology
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
‘The time is now’ for Australia to harness new vaccine technology
Save
Normal text size
Advertisement
The resurgence of COVID-19 cases in Sydney is a salient reminder of how crucial a successful vaccine will be in paving a path to normality.
News of a growing cluster of cases on Sydney’s northern beaches broke one week after
The federal government has also ordered doses of the Pfizer/BioNTech vaccine, which has shown efficacy of up to 95 per cent and has been the first coronavirus vaccine to launch into communities. However, there’s no chance of that vaccine being produced in Australia for the time being.

Related Keywords

Germany , Australia , Monash , South Australia , Melbourne , Victoria , Australian , German , Andrew Nash , Astrazeneca , Harry Al Wassiti , Nikolai Petrovsky , Paul Jeffers , Ted Franks , Colin Pouton , Pfizer , Monash University , Monash University Professor Colin Pouton , Sustainable Impact Fund , University Professor Colin Pouton , Impact Fund , South Australian , ஜெர்மனி , ஆஸ்திரேலியா , மோனாஷ் , தெற்கு ஆஸ்திரேலியா , மெல்போர்ன் , விக்டோரியா , ஆஸ்திரேலிய , ஜெர்மன் , ஆண்ட்ரூ நஷ் , பால் ஜெஃப்ஃபர்ஸ் , டெட் பிராங்குகள் , ஃபைசர் , மோனாஷ் பல்கலைக்கழகம் , நிலையான தாக்கம் நிதி , தாக்கம் நிதி , தெற்கு ஆஸ்திரேலிய ,